1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [1649d503-aba3-4c94-8b17-c3a8b5a04676] => Array ( [runtime-id] => 1649d503-aba3-4c94-8b17-c3a8b5a04676 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [04eaf521-2273-48ba-8f90-89a440692ded] => Array ( [runtime-id] => 04eaf521-2273-48ba-8f90-89a440692ded [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;e3fec5fe0a06799a65c95655dfdd0d6e4aafd3c2 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [1649d503-aba3-4c94-8b17-c3a8b5a04676] => Array ( [runtime-id] => 1649d503-aba3-4c94-8b17-c3a8b5a04676 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [04eaf521-2273-48ba-8f90-89a440692ded] => Array ( [runtime-id] => 04eaf521-2273-48ba-8f90-89a440692ded [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;e3fec5fe0a06799a65c95655dfdd0d6e4aafd3c2 ) ) )Table 1:Characteristics of the study participants
Characteristics No. of subjects 30 Female/male 24:6 Age (mean) (yr) 43 ± 12 Phenotype Relapsing-remitting MS 25 Secondary-progressive MS 5 Disease duration (median) (range) (yr) 6.5 (0.3–43.9) EDSS (median) (range) 1.75 (0–6.5)
Note:—EDSS indicates Expanded Disability Status Scale.